Health-Related Quality of Life among Patients with Hepatitis C Virus Infection: A Cross-Sectional Study in Jianping County of Liaoning Province, China
Table 2
CLDQ and EQ-5D scores among patients with CHC, LC, and healthy subjects.
Domain
HSs
CHC
LC
CLDQ
Abdominal symptoms
6.7 (6.0-7.0)
6.3 (5.0-7.0)
5.0 (3.0-6.9)
0.006
0.004
0.053
Fatigue
6.2 (5.4-6.6)
5.6 (4.0-6.6)
3.9 (2.1-5.9)
0.012
0.001
0.019
Systemic symptoms
6.2 (5.8-6.8)
5.6 (4.4-6.2)
3.4 (2.4-5.4)
<0.001
<0.001
0.001
Activity
6.7 (6.3-7.0)
5.7 (4.6-7.0)
4.0 (3.1-6.6)
<0.001
0.001
0.035
Emotional function
6.5 (5.8-6.9)
5.7 (4.5-6.5)
3.9 (2.9-5.9)
<0.001
<0.001
0.010
Worry
7.0 (6.6-6.0)
6.3 (4.6-7.0)
5.2 (3.5-7.0)
<0.001
0.003
0.281
Overall
6.4 (6.0-6.7)
5.8 (4.6-6.4)
4.1 (3.0-6.0)
<0.001
<0.001
0.008
EQ-5D
Index
1.0 (1.0-1.0)
1.0 (0.8-1.0)
0.9 (0.6-1.0)
0.001
0.003
0.138
VAS
85.0 (80.0-90.0)
60.0 (70.0-80.0)
60.0 (50.0-80.0)
<0.001
0.001
0.318
The data are expressed as median (interquartile range). CHC: chronic hepatitis C; LC: liver cirrhosis; HSs: healthy subjects; CLDQ: chronic liver disease questionnaire; EQ-5D: EuroQol-5D; VAS: visual analogue scale. HS vs. CHC, HS vs. LC, and CHC vs. LC.
